Super-Dragon Engineering Plastics
301131
Broadex Technologies
300548
Zhejiang Zhaofeng Mechanical And Electronic
300695
4
Jing-Jin Electric Technologies
688280
5
Hangzhou Anysoft Information Technology
300571
CN Stock MarketDetailed Quotes
300573 Shenyang Xingqi Pharmaceutical
- 82.19
- +10.18+14.14%
Market Closed Apr 29 15:00 CST
14.40BMarket Cap32.07P/E (TTM)
84.00High76.20Low215.29KlotVolume79.90Open72.01Pre Close1.73BTurnover15.99%Turnover Ratio42.61P/E (Static)175.25MShares213.8652wk High8.26P/B11.06BFloat Cap64.3852wk Low86.41Limit Up134.61MShs Float213.86Historical High57.61Limit Down10.83%Amplitude-1.60Historical Low2.64Dividend TTM80.38Avg Price73.28KlotAsk3.22%Div YieldTTM100Lot Size123.94KlotBid
Shenyang Xingqi Pharmaceutical Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 53.24%536.14M | 32.42%1.94B | 30.27%1.44B | 30.10%891.8M | 22.10%349.88M | 17.42%1.47B | 10.02%1.1B | 14.14%685.47M | -5.10%286.56M | 21.59%1.25B |
| Operating revenue | 53.24%536.14M | 32.42%1.94B | 30.27%1.44B | 30.10%891.8M | 22.10%349.88M | 17.42%1.47B | 10.02%1.1B | 14.14%685.47M | -5.10%286.56M | 21.59%1.25B |
| Other operating revenue | ---- | -30.06%19.49M | ---- | -18.82%11.61M | ---- | 20.08%27.86M | ---- | 937.96%14.3M | ---- | 544.94%23.2M |
| Total operating cost | 17.29%367.43M | 28.73%1.54B | 23.05%1.11B | 18.27%694.36M | 19.36%313.25M | 18.25%1.2B | 18.50%899.95M | 30.28%587.09M | 22.57%262.44M | 28.36%1.01B |
| Operating cost | 27.25%106.4M | 26.82%421.11M | 25.61%311.14M | 20.15%194.73M | 21.42%83.61M | 24.99%332.06M | 24.11%247.7M | 33.80%162.07M | 15.22%68.86M | 17.95%265.67M |
| Operating tax surcharges | 88.30%7.64M | 54.91%25.42M | 57.42%19.77M | 50.56%11.89M | 52.81%4.06M | 4.95%16.41M | 2.85%12.56M | 3.25%7.9M | -29.18%2.65M | 13.32%15.64M |
| Operating expense | 12.00%168.01M | 31.79%705.49M | 25.90%516.89M | 21.93%331.38M | 11.98%150.01M | 15.51%535.31M | 19.80%410.56M | 34.49%271.78M | 40.64%133.97M | 37.00%463.43M |
| Administration expense | -3.46%37.36M | 10.23%170.29M | 6.84%120.23M | 10.62%78.69M | 28.60%38.7M | 17.08%154.49M | -6.68%112.53M | -3.05%71.14M | -13.97%30.09M | 11.57%131.95M |
| Financial expense | 179.65%951.34K | 115.66%974.81K | 96.85%-155.63K | 70.26%-1.04M | 34.45%-1.19M | 23.06%-6.23M | 18.43%-4.95M | 16.26%-3.51M | 6.41%-1.82M | -231.94%-8.09M |
| -Interest expense (Financial expense) | 147.88%1.5M | 297.30%5.71M | 398.48%4.07M | 560.16%2.26M | 284.14%605.37K | 53.38%1.44M | 1.21%815.91K | -43.35%342.7K | -66.48%157.59K | -84.35%937.47K |
| -Interest Income (Financial expense) | 61.11%-718.88K | 28.51%-5.66M | 19.81%-4.75M | 7.64%-3.65M | 9.55%-1.85M | 20.34%-7.91M | 22.84%-5.92M | 25.88%-3.95M | 24.14%-2.04M | -1,096.03%-9.93M |
| Research and development | 23.65%47.07M | 31.90%220.66M | 14.75%139.48M | 1.28%78.7M | 32.72%38.07M | 14.89%167.3M | 34.39%121.55M | 53.58%77.71M | 28.56%28.68M | 64.64%145.61M |
| Credit Impairment Loss | -131.18%-370.83K | -23.77%-4.62M | 25.05%-3.27M | 20.03%-3.58M | 199.72%1.19M | -263.51%-3.73M | -11.89%-4.36M | -121.29%-4.47M | -279.72%-1.19M | -6,298.36%-1.03M |
| Asset Impairment Loss | -463.56%-6.4M | 58.81%-3.42M | -12.44%-3.1M | 32.74%-1.74M | 134.36%1.76M | -88.28%-8.29M | -5,545.02%-2.75M | -673.67%-2.58M | -849.64%-5.12M | -17.12%-4.41M |
| Other net revenue | -11.22%9.44M | 205.09%25.31M | 195.14%20.38M | 289.58%11.29M | 949.02%10.63M | -42.65%8.3M | -11.51%6.9M | -11.54%2.9M | -1,207.11%-1.25M | 35.90%14.47M |
| Invest income | ---- | ---24.24K | ---24.24K | ---24.24K | ---- | ---- | ---- | ---- | ---- | ---- |
| Asset deal income | --32.1K | -2,506.63%-978.36K | 421.82%101.67K | 589.43%154.62K | ---- | -108.92%-37.53K | -2,061.53%-31.59K | -2,061.53%-31.59K | ---- | -91.85%420.75K |
| Other revenue | 110.64%16.18M | 68.71%34.35M | 89.79%26.66M | 65.02%16.48M | 51.66%7.68M | 4.53%20.36M | 20.59%14.05M | 77.24%9.98M | 423.87%5.06M | 218.55%19.48M |
| Operating profit | 277.02%178.15M | 53.61%424.75M | 66.33%352.31M | 106.09%208.74M | 106.63%47.25M | 10.56%276.52M | -16.14%211.82M | -33.89%101.28M | -74.00%22.87M | 0.69%250.1M |
| Add:Non operating Income | --905 | 205.45%291.89K | 189.07%247.33K | -67.57%25.16K | ---- | -96.84%95.56K | -95.86%85.56K | 15.26%77.56K | 1,467.82%110.51K | -58.20%3.02M |
| Less:Non operating expense | -89.05%612.66K | 158.22%30.01M | 59.56%14.7M | 1.67%8.44M | 408.65%5.6M | -40.12%11.62M | -46.44%9.21M | -42.83%8.3M | -50.23%1.1M | 60.54%19.41M |
| Total profit | 326.19%177.53M | 49.07%395.03M | 66.69%337.86M | 115.26%200.33M | 90.40%41.66M | 13.38%264.99M | -14.64%202.69M | -32.93%93.06M | -74.49%21.88M | -4.03%233.72M |
| Less:Income tax cost | 358.07%31.64M | 128.27%56.97M | 131.32%47.1M | 484.20%31M | 173.19%6.91M | 13.27%24.96M | -41.20%20.36M | -70.71%5.31M | -78.18%2.53M | -36.01%22.03M |
| Net profit | 319.86%145.9M | 40.84%338.06M | 59.47%290.76M | 92.95%169.32M | 79.59%34.75M | 13.39%240.04M | -10.11%182.33M | -27.25%87.75M | -73.91%19.35M | 1.23%211.68M |
| Net profit from continuing operation | 319.86%145.9M | 40.84%338.06M | 59.47%290.76M | 92.95%169.32M | 79.59%34.75M | 13.39%240.04M | -10.11%182.33M | -27.25%87.75M | -73.91%19.35M | 1.23%211.68M |
| Net profit of parent company owners | 319.86%145.9M | 40.84%338.06M | 59.47%290.76M | 92.95%169.32M | 79.59%34.75M | 13.39%240.04M | -10.11%182.33M | -27.25%87.75M | -73.91%19.35M | 8.72%211.68M |
| Earning per share | ||||||||||
| Basic earning per share | 315.00%0.83 | 40.58%1.94 | 59.05%1.67 | 90.20%0.97 | 25.00%0.2 | -19.77%1.38 | -35.98%1.05 | -62.77%0.51 | -80.95%0.16 | -28.03%1.72 |
| Diluted earning per share | 315.00%0.83 | 39.86%1.93 | 59.05%1.67 | 90.20%0.97 | 25.00%0.2 | -19.77%1.38 | -35.98%1.05 | -62.77%0.51 | -80.95%0.16 | -27.73%1.72 |
| Other composite income | ||||||||||
| Total composite income | 319.86%145.9M | 40.84%338.06M | 59.47%290.76M | 92.95%169.32M | 79.59%34.75M | 13.39%240.04M | -10.11%182.33M | -27.25%87.75M | -73.91%19.35M | 0.98%211.68M |
| Total composite income of parent company owners | 319.86%145.9M | 40.84%338.06M | 59.47%290.76M | 92.95%169.32M | 79.59%34.75M | 13.39%240.04M | -10.11%182.33M | -27.25%87.75M | -73.91%19.35M | 8.43%211.68M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.